RUSSIA: Russia Rejects Methadone to Stem HIV Epidemic

Important note: Information in this article was accurate in 2009. The state of the art may have changed since the publication date.

RUSSIA: Russia Rejects Methadone to Stem HIV Epidemic

Agence France Presse (10.28.09) - Wednesday, October 28, 2009

More than 60 percent of people with HIV in Eastern Europe and Central Asia acquired the virus through injection drug use, Russia's chief medical official said Wednesday. However, Russia will not be embracing methadone maintenance treatment for injection drug users (IDUs), Gennady Onishchenko told the Eastern Europe and Central Asia AIDS Conference in Moscow. More than 500,000 people are officially listed as HIV-positive in Russia.

"The danger is that the epidemic will cross over from a concentrated one to a general one," Onishchenko said. Russia offers IDUs effective programs other than methadone maintenance, he said. "Russia speaks out categorically against this component in prevention programs," he said, noting that the synthetic drug is illegal in the country. "We aren't simply denying this problem, we are proposing our solution," he added.

At the conference, international speakers criticized Russia's policy against methadone, which is given to IDUs to help them cease drug injection. The International AIDS Society and the Eurasian Harm Reduction Network released a statement urging Russia to support methadone programs.

Such interventions are "an essential element of universal access to HIV prevention," said Michel Sidibe, executive director of UNAIDS. "I fear that in this region the legal barrier to harm-reduction programs also makes [IDUs] a target for harassment, driving the people most affected by this epidemic underground," he said. "I urge each country in this region to define within its own legislation the harm-reduction program it needs, just like China has done with great success."
091028
AD091850

Copyright © 2009 - Information, Inc., Bethesda, MD. The CDC National Center for HIV, STD and TB Prevention provides the following information as a public service only. Providing synopses of key scientific articles and lay media reports on HIV/AIDS, other sexually transmitted diseases and tuberculosis does not constitute CDC endorsement. This daily update also includes information from CDC and other government agencies, such as background on Morbidity and Mortality Weekly Report (MMWR) articles, fact sheets, press releases and announcements. Reproduction of this text is encouraged; however, copies may not be sold, and the CDC HIV/STD/TB Prevention News Update should be cited as the source of the information. Contact the sources of the articles abstracted below for full texts of the articles.

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from the Elton John AIDS Foundation, National Library of Medicine, AIDS Walk of Orange County, and donations from users like you.

Always watch for outdated information. This article first appeared in 2009. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 2009. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content.